Cannabotech Ltd. Logo

Cannabotech Ltd.

Develops therapies by integrating cannabinoids and medicinal mushroom extracts.

CNTC | TA

Overview

Corporate Details

ISIN(s):
IL0011769085
LEI:
Country:
Israel
Address:
3 Arik Einstein, 4659071 Herzliya

Description

Cannabotech Ltd. is a biomedical company developing therapeutic solutions by integrating cannabinoids and medicinal mushroom extracts. The company's activities encompass both pharmaceutical development and consumer wellness. Its pharmaceutical research focuses on treatments for oncology and inflammatory diseases. Concurrently, Cannabotech markets a consumer product line based on its proprietary M2CBD formula, which synergistically combines highly bioavailable CBD with patented functional mushroom varieties. These supplements and topical products are formulated to support immunity, sleep, and stress management, promoting a preventative approach to health and well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-03 16:01
Changes in the company's name and security's name, effective as of December 7, …
English 125.1 KB
2025-02-10 17:47
Base price of 1 agora and unlimited price fluctuation
Hebrew (modern) 90.8 KB
2025-01-09 10:41
Capital consolidation 10:1, There will be no trading in the company's shares on…
Hebrew (modern) 77.6 KB
2024-11-12 18:33
Trading in the company's shares (ISIN IL0011769085) will be renewed on Thursday…
Hebrew (modern) 158.8 KB
2024-10-01 10:13
Suspension due to failure in publication of financial reports
Hebrew (modern) 79.6 KB
2024-09-29 17:58
CANNABOTECH– Appointment of a Market Maker
Hebrew (modern) 151.8 KB
2024-09-23 19:44
Failure in publishing financial reports-Notification
Hebrew (modern) 127.4 KB
2024-09-02 15:06
Discontinuation of Market Making
Hebrew (modern) 92.1 KB
2022-01-11 15:43
Opening of Trading on January 12 2022- CANNABOTECH W3
Hebrew (modern) 253.5 KB
2022-01-10 10:54
Identifying Details of New Security-CANNABOTECH W3
Hebrew (modern) 174.6 KB
2021-09-13 19:45
will not be added TA-Tech Elite Index
Hebrew (modern) 82.9 KB
2021-07-25 18:17
Fast Track to TA-Tech Elite Index as on October 7th, 2021 at the end of the tra…
Hebrew (modern) 162.5 KB
2021-07-25 16:07
Appointment of a Market Maker
Hebrew (modern) 210.0 KB
2021-07-21 18:34
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) 244.6 KB
2021-06-15 16:11
Identifying Details of New Securities - CANNABOTECH, CANNABOTECH W1, CANNABOTEC…
Hebrew (modern) 155.0 KB

Automate Your Workflow. Get a real-time feed of all Cannabotech Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cannabotech Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cannabotech Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.